|
acute myeloïde leukemie met inv(3)(q21.3;q26.2) of t(3;3)(q21.3;q26.2); GATA2, MECOM (aandoening)
acute myeloïde leukemie met inv(3)(q21.3;q26.2) of t(3;3)(q21.3;q26.2); GATA2, MECOM
AML met inv(3)(q21.3q26.2) of t(3;3)(q21.3;q26.2); RPN1-EVI1
Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1
A subtype of acute myeloid leukemia with recurrent genetic abnormalities characterized by clonal proliferation of myeloid blasts in the bone marrow, blood and rarely other tissues. Bone marrow typically shows small hypo-lobated megakaryocytes and multilineage dysplasia. Patients typically present with leukocytosis, anemia, and variable platelet counts and a variety of nonspecific symptoms related to ineffective hematopoesis (fatigue, bleeding, bruising, recurrent infections, bone pain) and/or extramedullary site involvement (gingivitis, splenomegaly). High resistance to conventional chemotherapy is reported.
Id780844005
StatusDefined
DHD Diagnosis thesaurus reference set
RIVM authorized national diagnosis thesaurus to ICD10 complex mapping reference set
TargetC92.0
TermAcute myeloblastenleukemie [AML]
SNOMED CT to Orphanet simple map402020
SNOMED CT to ICD-10 extended map
TargetC92.0
RuleTRUE
AdviceALWAYS C92.0 | POSSIBLE REQUIREMENT FOR MORPHOLOGY CODE
CorrelationSNOMED CT source code to target map code correlation not specified